Pharmafile Logo
Pharmafocus logo
Advanced Search

Metabolex

Showing 2 posts of 2 posts found.

Sanofi headquarters

Sanofi abandons $375m oral diabetes deal

May 9, 2011
Sales and Marketing Metabolex, Sanofi, diabetes

Sanofi has terminated its $375 million deal with US biotech Metabolex to develop a novel oral anti-diabetic treatment. The French …

News

Sanofi licences novel oral anti-diabetic treatment

June 25, 2010
Research and Development, Sales and Marketing Metabolex, Sanofi-Aventis, diabetes

Sanofi-Aventis has signed an exclusive worldwide licensing agreement with US-based diabetes specialist Metabolex for a novel oral anti-diabetic treatment. MBX-2982 …

News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026